Home » Stocks » HSKA

Heska Corporation (HSKA)

Stock Price: $171.55 USD 4.67 (2.80%)
Updated Mar 5, 2021 3:59 PM EST - Market closed
Market Cap 1.58B
Revenue (ttm) 197.32M
Net Income (ttm) -14.40M
Shares Out 8.65M
EPS (ttm) -1.66
PE Ratio n/a
Forward PE 243.90
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $171.55
Previous Close $166.88
Change ($) 4.67
Change (%) 2.80%
Day's Open 166.48
Day's Range 165.59 - 172.05
Day's Volume 177,616
52-Week Range 50.00 - 217.17

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 2 days ago

LOVELAND, Colo., March 2, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, t...

PRNewsWire - 4 days ago

LOVELAND, Colo., March 1, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, t...

Benzinga - 1 week ago

Shares of Heska (NASDAQ:HSKA) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 928.57% over the past year to $0.72, which beat the estimate of...

PRNewsWire - 1 month ago

LOVELAND, Colo., Jan. 12, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, appoi...

Seeking Alpha - 2 months ago

Heska Corporation's current financial performance illustrates the advantage of geographic spread very well. The benefit of scale and efficiency of HKSA's operations is evident in how neatly it...

Seeking Alpha - 3 months ago

Heska Corporation (HSKA) CEO Kevin Wilson on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Heska (HSKA) delivered earnings and revenue surprises of 166.67% and 16.66%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 4 months ago

Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 6 months ago

Heska's (HSKA) CEO Kevin Wilson on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 9 months ago

Heska's (HSKA) CEO Kevin Wilson on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

Heska (HSKA) delivered earnings and revenue surprises of 44.00% and -8.40%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 9 months ago

Shares of Heska (NASDAQ:HSKA) remained unaffected at $70.17 after the company reported Q1 results.

The Motley Fool - 11 months ago

But now, the agency isn't so sure about whether people can transmit the disease to dogs and cats.

Other stocks mentioned: IDXX, ZTS
Seeking Alpha - 1 year ago

Heska Corporation (HSKA) CEO Kevin Wilson on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Heska (HSKA) delivered earnings and revenue surprises of 133.33% and -1.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Forbes - 1 year ago

See two of the featured stocks from this month’s model portfolios.

Other stocks mentioned: CHRW
Seeking Alpha - 1 year ago

Heska Corporation (HSKA) CEO Kevin Wilson on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Heska (HSKA) delivered earnings and revenue surprises of 25.00% and 2.61%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Heska Corporation (HSKA) CEO Kevin Wilson on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Heska Corporation (HSKA) CEO Kevin Wilson on Q1 2019 Results - Earnings Call Transcript

About HSKA

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal segment offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and HemaTrue veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Jun 30, 1997
CEO
Kevin Wilson
Employees
602
Stock Exchange
NASDAQ
Ticker Symbol
HSKA
Full Company Profile

Financial Performance

In 2020, HSKA's revenue was $197.32 million, an increase of 60.87% compared to the previous year's $122.66 million. Losses were -$14.40 million, 882.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for HSKA stock is "Buy." The 12-month stock price forecast is 208.25, which is an increase of 21.39% from the latest price.

Price Target
$208.25
(21.39% upside)
Analyst Consensus: Buy